Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

書誌詳細
主要な著者:	Hennekens, C, Buring, J, Sandercock, P, Collins, R, Peto, R
フォーマット:	Journal article
言語:	English
出版事項:	1989

類似資料

Aspirin and stroke.
著者:: Buring, J, 等
出版事項: (1990)

ASPIRIN USE AND CHRONIC DISEASES
著者:: Hennekens, C, 等
出版事項: (1990)

Aspirin in ischemic heart disease.
著者:: Hennekens, C, 等
出版事項: (1992)

Low-dose aspirin for migraine prophylaxis.
著者:: Buring, J, 等
出版事項: (1990)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
著者:: Baigent, C, 等
出版事項: (2009)

Antioxidant vitamins, cancer, and cardiovascular disease - Reply
著者:: Hennekens, C, 等
出版事項: (1996)

Antiplatelet agents in stroke prevention.
著者:: Peto, R
出版事項: (1988)

Aspirin in the primary prevention of vascular disease Reply
著者:: Baigent, C, 等
出版事項: (2009)

Aspirin in the primary prevention of vascular disease Reply
著者:: Baigent, C, 等
出版事項: (2009)

Prevention. Aspirin in primary prevention--good news and bad news.
著者:: Hennekens, C, 等
出版事項: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
著者:: Hennekens, C, 等
出版事項: (2012)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
著者:: Collins, R, 等
出版事項: (1994)

TRIALS OF ANTIPLATELET THERAPY - REPLY
著者:: Baigent, C, 等
出版事項: (1994)

Polypills with or without aspirin for primary prevention of cardiovascular disease
著者:: Mant, J, 等
出版事項: (2021)

Role of aspirin in primary prevention of cardiovascular disease
著者:: Patrono, C, 等
出版事項: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
著者:: VanWormer JJ, 等
出版事項: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
著者:: Ying Xing, 等
出版事項: (2019-07-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
出版事項: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
著者:: Randall S Stafford, 等
出版事項: (2005-12-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
著者:: Guillaume Marquis‐Gravel, 等
出版事項: (2024-02-01)

An overview of the British and American aspirin studies.
著者:: Hennekens, C, 等
出版事項: (1988)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
著者:: Hennekens, C, 等
出版事項: (2006)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
著者:: L. O. Minushkina
出版事項: (2017-12-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
著者:: Lozano R, 等
出版事項: (2015-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
著者:: Yinong Chen, 等
出版事項: (2021-09-01)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
著者:: Fernández-de-Bobadilla Jaime, 等
出版事項: (2007-10-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
著者:: Sergio Coccheri
出版事項: (2017-04-01)

Antiplatelet treatment in primary and secondary stroke prevention in women.
著者:: Caso, V, 等
出版事項: (2012)

Antiplatelet treatment in primary and secondary stroke prevention in women
著者:: Caso, V, 等
出版事項: (2012)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
著者:: Mikkel B. Christensen, 等
出版事項: (2021-06-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
著者:: Price, H, 等
出版事項: (2009)

Aspirin for prevention of cancer and cardiovascular disease.
著者:: Rose, P, 等
出版事項: (2011)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
著者:: Patrono, C, 等
出版事項: (2010)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
著者:: Nischal N Hegde, 等
出版事項: (2023-01-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
著者:: Eleni Giannopoulou, 等
出版事項: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
著者:: Athena L. Huang, 等
出版事項: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
著者:: Athena L. Huang, MD, 等
出版事項: (2023-09-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
著者:: N. В. Perepech, 等
出版事項: (2018-05-01)

Antiplatelets in secondary stroke prevention
著者:: Olga eShulga, 等
出版事項: (2011-07-01)

Antioxidant vitamins--benefits not yet proved.
著者:: Hennekens, C, 等
出版事項: (1994)